Evidence map›Paper›PMID 42073843›Full record

ArticleBehavioral sciences (Basel, Switzerland)2026

Ketamine Use in Self-Described Therapeutic Contexts: A Thematic Analysis of Reddit Posts.

Jared Kendrick, Ghonwa Ahmad, Audrey Wood, Samuel Stumo, Aarav Sehgal, Douglas B Matthews, Pravesh Sharma

Abstract read
In one paragraph

Article in Behavioral sciences (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jared KendrickDepartment of Psychology, University of Wisconsin-Eau Claire, 124 Garfield Ave., Eau Claire, WI 54701, USA.
Ghonwa AhmadFaculty of Medicine, Yarmouk University, Shafiq Irshidat St., Irbid 21163, Jordan.
Audrey WoodDepartment of Psychology, University of Wisconsin-Eau Claire, 124 Garfield Ave., Eau Claire, WI 54701, USA.
Samuel StumoDepartment of Psychology, University of Wisconsin-Eau Claire, 124 Garfield Ave., Eau Claire, WI 54701, USA.ORCID 0009-0005-2992-9141
Aarav SehgalSachem High School East, 177 Granny Rd., Farmingville, NY 11738, USA.
Douglas B MatthewsDepartment of Psychology, University of Wisconsin-Eau Claire, 124 Garfield Ave., Eau Claire, WI 54701, USA.ORCID 0000-0002-6518-4280
Pravesh SharmaDepartment of Psychiatry and Psychology, Mayo Clinic Health System, 1221 Whipple Street, Eau Claire, WI 54703, USA.ORCID 0000-0002-9503-5016

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of ketamine for the management of neuropsychiatric conditions outside clinical settings has rapidly expanded, creating a critical need to understand diverse individual experiences. We conducted a qualitative content analysis of posts from the r/TherapeuticKetamine subreddit. From 3302 threads, the 500 highest-engagement threads (12,852 comments) were analyzed by independent coders across six domains: perceived positive effects, adverse effects, reasons for use, route of administration, polydrug use, and dose amounts. Mood-related concerns were the primary reason for use (53%). Users reported positive effects, most often improvements in emotional well-being (65%). Adverse effects were predominantly psychological or mood-related (56%). A total of 70% of reported doses exceeded 149 mg, suggesting a trend toward higher dose use. Intravenous administration (40%) and sublingual troches (23%) were the most frequently reported routes. Concurrent use of prescribed psychotropics, cannabis, and psychedelics was also reported. This analysis identified substantial heterogeneity in individual-reported experiences. Frequent high-dose use, dose escalation, and polydrug exposure underscores the importance of clinical monitoring and attention to addiction potential and drug-drug interactions. The findings should be interpreted with caution, as follow-up and clinical verification were not possible; however, the data provide an unfiltered view of individual experiences in relation to ketamine use outside the clinical setting.

Indexed as

ketamineredditthematic analysisuser experience

Identifiers

PMID42073843
PMCPMC13113285

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.